Khondrion’s sonlicromanol produces encouraging results for next stage of study
Biopharma company, Khondrion, has marked announced improvements from patients with MELAS spectrum disorders taking its…
December 2, 2022 - 2 minutes
mitochondria
Khondrion’s mitochondrial diseases treatment producing positive results
Clinical-stage pharmaceutical company, Khondrion, discovering and developing therapies targeting primary mitochondrial diseases announced yesterday (November…
November 23, 2022 - 5 minutes
NRG Therapeutics selects Domainex for project aimed at finding candidate for neurogenerative disorders
A neuroscience company targeting mitochondrial dysfunction has teamed up with an organization developing small molecule…
June 30, 2022 - 3 minutes
Mitochondria in focus as 4BIO Capital co-leads $30.3M financing in LUCA Science
4BIO Capital, an international venture capital firm focusing on the advanced therapies sector, has co-led…
June 6, 2022 - 3 minutes
